217 related articles for article (PubMed ID: 24357461)
1. Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Nakao K
Clin Exp Nephrol; 2014 Aug; 18(4):584-92. PubMed ID: 24357461
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
[TBL] [Abstract][Full Text] [Related]
3. Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk.
Hata Y; Kuwabara T; Mori K; Kan Y; Sato Y; Umemoto S; Fujimoto D; Kanki T; Nishiguchi Y; Yokoi H; Kakizoe Y; Izumi Y; Yanagita M; Mukoyama M
Sci Rep; 2020 Feb; 10(1):3056. PubMed ID: 32080297
[TBL] [Abstract][Full Text] [Related]
4. Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases.
Kuwabara T; Mori K; Kasahara M; Yokoi H; Imamaki H; Ishii A; Koga K; Sugawara A; Yasuno S; Ueshima K; Morikawa T; Konishi Y; Imanishi M; Nishiyama A; Nakao K; Mukoyama M
PLoS One; 2014; 9(2):e88942. PubMed ID: 24558454
[TBL] [Abstract][Full Text] [Related]
5. Globo-series glycosphingolipids enhance Toll-like receptor 4-mediated inflammation and play a pathophysiological role in diabetic nephropathy.
Nitta T; Kanoh H; Inamori KI; Suzuki A; Takahashi T; Inokuchi JI
Glycobiology; 2019 Mar; 29(3):260-268. PubMed ID: 30476082
[TBL] [Abstract][Full Text] [Related]
6. MiR-874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor-4.
Yao T; Zha D; Gao P; Shui H; Wu X
J Cell Physiol; 2018 Jan; 234(1):871-879. PubMed ID: 30171701
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
8. Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus.
Mallipattu SK; Gallagher EJ; LeRoith D; Liu R; Mehrotra A; Horne SJ; Chuang PY; Yang VW; He JC
Am J Physiol Renal Physiol; 2014 May; 306(9):F1008-17. PubMed ID: 24598803
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
10. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
[TBL] [Abstract][Full Text] [Related]
11. Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages.
Wang J; Vodovotz Y; Fan L; Li Y; Liu Z; Namas R; Barclay D; Zamora R; Billiar TR; Wilson MA; Fan J; Jiang Y
FASEB J; 2015 Jan; 29(1):250-62. PubMed ID: 25342131
[TBL] [Abstract][Full Text] [Related]
12. Platelet-neutrophil interaction aggravates vascular inflammation and promotes the progression of atherosclerosis by activating the TLR4/NF-κB pathway.
Liang X; Xiu C; Liu M; Lin C; Chen H; Bao R; Yang S; Yu J
J Cell Biochem; 2019 Apr; 120(4):5612-5619. PubMed ID: 30302814
[TBL] [Abstract][Full Text] [Related]
13. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
14. Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes.
Yonekawa K; Neidhart M; Altwegg LA; Wyss CA; Corti R; Vogl T; Grigorian M; Gay S; Lüscher TF; Maier W
Atherosclerosis; 2011 Oct; 218(2):486-92. PubMed ID: 21782178
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of 1,25-dihydroxyvitamin D3 in monocytes cultured in serum from patients with type 2 diabetes mellitus and diabetic nephropathy with uremia via Toll-like receptor 4 and nuclear factor-κB p65.
Yang M; Xu J; Yu J; Yang B; Gan H; Li S; Li X
Mol Med Rep; 2015 Dec; 12(6):8215-22. PubMed ID: 26497229
[TBL] [Abstract][Full Text] [Related]
17. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
18. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
Jialal I; Major AM; Devaraj S
J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
[TBL] [Abstract][Full Text] [Related]
19. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
20. Suppression of TLR4 by miR-448 is involved in Diabetic development via regulating Macrophage polarization.
Zhao Q; Wang X; Hu Q; Zhang R; Yin Y
J Pharm Pharmacol; 2019 May; 71(5):806-815. PubMed ID: 30536833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
